Search Results for "Manta Trial Avastin"
Original Source: Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
Angiogenesis plays a key role in the development of choroidal neovascularizations (CNV) in age-related macular degeneration. Vascular endothelial growth factor (VEGF) is the most important factor involved in this angiogenetic processes in the eye. This forms the basis for new therapeutic interventions in exudative AMD. Currently two drugs have been approved by the FDA and one drug is used off-label. All these drugs are administered intravitreally. The present study aims to dire...
Matching Channels
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
Clinical Approvals - news, views, reports and blogs
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and eff...
Xofigo (radium-223 dichloride)
New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...
Research has not found any adverse effects from consuming vitamin E in food. However, high doses of alpha-tocopherol supplements can cause hemorrhage and interrupt blood coagulation in animals, and...
Contract Research Organization news
A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...
Matching News
Avastin unraveled by stratification study, Roche seeks validation
Reanalysis of Avastin registration trial brings Roche strategy for making universal Avastin use in oncology into question again. Study suggests less than half of Avastin treated colorectal cancer pat...
Zoology: Live birth without a placenta
Some sharks and rays give birth to live young but lack placentas or umbilical cords. So how do their embryos obtain oxygen?Taketeru Tomita of the Hokkaido University Museum in Hakodate, Japan, and his...
ASCO: Avastin slowed risk of cancer progression in platinum-resistant ovarian cancer
In the AURELIA trial, the first randomised trial of Roche’s Avastin (bevacizumab) in platinum-resistant ovarian cancer, it was shown that Avastin plus chemotherapy provides statistically signifi...
Lilly's Alimta misses maintenance therapy endpoint in NSCLC
Eli Lilly and Co. (NYSE:LLY) said maintenance therapy with Alimta pemetrexed plus Avastin bevacizumab missed the primary endpoint of improving median overall survival (OS) vs. Avastin alone in the Pha...
Torisel-Avastin combo fails in kidney cancer
Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to a new Phase III trial investigating the two drugs as a fir...
Avastin sees success in brain cancer trial
A late-stage study has shown that Roche’s oncology drug Avastin, when added to standard therapy, can help people with brain cancer live longer without the disease getting worse. In the Phase III AVA...
NICE rebuffs Avastin for first-line ovarian cancer
The U.K.'s NICE issued draft guidance recommending against Avastin bevacizumab from Roche (SIX:ROG; OTCQX:RHHBY) for first-line treatment of advanced ovarian cancer in combination with paclitaxel and...
Toxicity Shuts Down Avastin Trial in NSCLC (CME/CE)
BOSTON (MedPage Today) -- Unacceptable toxicity has at least temporarily derailed efforts to incorporate the angiogenesis inhibitor bevacizumab (Avastin) into chemoradiation for inoperable non-small c...
Matching PubMed Articles
Bio-inspired engineering. Manta machines.
FDA. Once on 'fast track,' avastin now derailed.
Changing End Points in Breast-Cancer Drug Approval - The Avastin Story.
In December 2007, the Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration (FDA) met to discuss the risks and benefits of Genentech's Avastin (bevacizumab) for use in combinat...
